These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7536309)

  • 1. The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation.
    Cutrer FM; Moussaoui S; Garret C; Moskowitz MA
    Neuroscience; 1995 Feb; 64(3):741-50. PubMed ID: 7536309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.
    Cutrer FM; Limmroth V; Ayata G; Moskowitz MA
    Br J Pharmacol; 1995 Dec; 116(8):3199-204. PubMed ID: 8719796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.
    Nozaki K; Moskowitz MA; Boccalini P
    Br J Pharmacol; 1992 Jun; 106(2):409-15. PubMed ID: 1327382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space.
    Nozaki K; Boccalini P; Moskowitz MA
    Neuroscience; 1992 Aug; 49(3):669-80. PubMed ID: 1501769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis.
    Mitsikostas DD; Sanchez del Rio M; Waeber C; Moskowitz MA; Cutrer FM
    Pain; 1998 May; 76(1-2):239-48. PubMed ID: 9696479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.
    Cutrer FM; Schoenfeld D; Limmroth V; Panahian N; Moskowitz MA
    Br J Pharmacol; 1995 Mar; 114(5):987-92. PubMed ID: 7780655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis.
    Cutrer FM; Yu XJ; Ayata G; Moskowitz MA; Waeber C
    Neuropharmacology; 1999 Jul; 38(7):1043-53. PubMed ID: 10428423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective blockade of substance P or neurokinin A receptors reduces the expression of c-fos in trigeminal subnucleus caudalis after corneal stimulation in the rat.
    Bereiter DA; Bereiter DF; Tonnessen BH; Maclean DB
    Neuroscience; 1998 Mar; 83(2):525-34. PubMed ID: 9460760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of Fos-like immunoreactivity in the trigeminal nucleus caudalis following trigeminovascular activation in the anaesthetised guinea-pig.
    Clayton JS; Gaskin PJ; Beattie DT
    Brain Res; 1997 Nov; 775(1-2):74-80. PubMed ID: 9439830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation by butalbital of capsaicin-induced c-fos-like immunoreactivity in trigeminal nucleus caudalis.
    Cutrer FM; Mitsikostas DD; Ayata G; Sanchez del Rio M
    Headache; 1999; 39(10):697-704. PubMed ID: 11279945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva.
    Lee WS; Moussaoui SM; Moskowitz MA
    Br J Pharmacol; 1994 Jul; 112(3):920-4. PubMed ID: 7921621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis.
    Mitsikostas DD; Sanchez del Rio M; Waeber C
    Cephalalgia; 2002 Jun; 22(5):384-94. PubMed ID: 12110114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation.
    Goadsby PJ; Hoskin KL; Knight YE
    Neuroscience; 1998 Sep; 86(1):337-43. PubMed ID: 9692766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous activation of N-methyl-D-aspartate and neurokinin-1 receptors modulates c-Fos and Zif/268 expression in the rat trigeminal nucleus caudalis.
    Koganemaru M; Takasaki M; Nishimori T
    Neuroscience; 2000; 98(2):317-23. PubMed ID: 10854763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
    Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
    Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms.
    Moskowitz MA; Nozaki K; Kraig RP
    J Neurosci; 1993 Mar; 13(3):1167-77. PubMed ID: 8382735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-FOS expression in the rat brain in response to substance P and neurokinin B.
    Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
    Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brainstem neurons expressing c-Fos immunoreactivity following irritant chemical stimulation of the rat's tongue.
    Carstens E; Saxe I; Ralph R
    Neuroscience; 1995 Dec; 69(3):939-53. PubMed ID: 8596661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of capsaicin-induced trigeminal Fos-like immunoreactivity by 5-HT(7) receptors.
    Martínez-García E; Leopoldo M; Lacivita E; Terrón JA
    Headache; 2011; 51(10):1511-9. PubMed ID: 22082421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet irradiation of the eye and Fos-positive neurons induced in trigeminal brainstem after intravitreal or ocular surface transient receptor potential vanilloid 1 activation.
    Chang Z; Okamoto K; Tashiro A; Bereiter DA
    Neuroscience; 2010 Oct; 170(2):678-85. PubMed ID: 20643195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.